125 related articles for article (PubMed ID: 35899960)
1. Galbanic Acid Improves Accumulation and Toxicity of Arsenic Trioxide in MT-2 Cells.
Mahdifar M; Rassouli FB; Iranshahi M; Goudarzi S; Golizadeh M; Rafatpanah H
Anticancer Agents Med Chem; 2023; 23(6):699-708. PubMed ID: 35899960
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide induces accumulation of cytotoxic levels of ceramide in acute promyelocytic leukemia and adult T-cell leukemia/lymphoma cells through de novo ceramide synthesis and inhibition of glucosylceramide synthase activity.
Dbaibo GS; Kfoury Y; Darwiche N; Panjarian S; Kozhaya L; Nasr R; Abdallah M; Hermine O; El-Sabban M; de Thé H; Bazarbachi A
Haematologica; 2007 Jun; 92(6):753-62. PubMed ID: 17550847
[TBL] [Abstract][Full Text] [Related]
3. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
Wang R; Liu C; Xia L; Zhao G; Gabrilove J; Waxman S; Jing Y
Clin Cancer Res; 2012 Dec; 18(24):6690-701. PubMed ID: 23082001
[TBL] [Abstract][Full Text] [Related]
4. Combination of auraptene and arsenic trioxide induces apoptosis and cellular accumulation in the subG1 phase in adult T-cell leukemia cells.
Kazemi M; Kouhpeikar H; Delbari Z; Khodadadi F; Gerayli S; Iranshahi M; Mosavat A; Behnam Rassouli F; Rafatpanah H
Iran J Basic Med Sci; 2021 Dec; 24(12):1643-1649. PubMed ID: 35432798
[TBL] [Abstract][Full Text] [Related]
5. Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade.
Boyko-Fabian M; Niehr F; Distel L; Budach V; Tinhofer I
PLoS One; 2014; 9(6):e98867. PubMed ID: 24927258
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL.
Liu Q; Hilsenbeck S; Gazitt Y
Blood; 2003 May; 101(10):4078-87. PubMed ID: 12531793
[TBL] [Abstract][Full Text] [Related]
7. Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.
Ghaffari SH; Bashash D; Dizaji MZ; Ghavamzadeh A; Alimoghaddam K
Tumour Biol; 2012 Feb; 33(1):157-72. PubMed ID: 22072212
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide and the growth of human T-cell leukemia virus type I infected T-cell lines.
Ishitsuka K; Hanada S; Uozumi K; Utsunomiya A; Arima T
Leuk Lymphoma; 2000 May; 37(5-6):649-55. PubMed ID: 11042529
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
[TBL] [Abstract][Full Text] [Related]
11. [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a].
Ye YB; Xu XJ; Chen YH; Zhang MW; Qiu DF; Guo ZW; He HQ
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):256-262. PubMed ID: 28550664
[No Abstract] [Full Text] [Related]
12. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines.
Gu J; Zhu X; Li Y; Dong D; Yao J; Lin C; Huang K; Hu H; Fei J
Med Oncol; 2011 Mar; 28(1):211-8. PubMed ID: 20143188
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2.
Wu X; Shi J; Wu Y; Tao Y; Hou J; Meng X; Hu X; Han Y; Jiang W; Tang S; Zangari M; Tricot G; Zhan F
Cancer Biol Ther; 2010 Dec; 10(11):1201-14. PubMed ID: 20953137
[TBL] [Abstract][Full Text] [Related]
14. Comparing toxicity of galbanic acid, auraptene and umbelliprenin on adult T-cell leukaemia-lymphoma in normoxia and hypoxia.
Goudarzi S; Rassouli FB; Kahrizi D; Paryan Shirkhani ; Mahdifar M; Mehrdad Iranshahi ; Houshang Rafatpanah ; Keramati MR; Hossein Ayatollahi
Cell Mol Biol (Noisy-le-grand); 2022 Dec; 68(12):17-20. PubMed ID: 37130187
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial Effect of Arsenic and Herbal Compounds in Telomerase-Mediated Apoptosis Induction in Liver Cancer.
Chaudhary A; Bhardwaj SK; Khan A; Srivastava A; Sinha KK; Ali M; Haque R
Biol Trace Elem Res; 2023 Jul; 201(7):3300-3310. PubMed ID: 36192614
[TBL] [Abstract][Full Text] [Related]
16. Synergy between parthenolide and arsenic trioxide in adult T-cell leukemia/lymphoma cells
Kouhpaikar H; Sadeghian MH; Rafatpanah H; Kazemi M; Iranshahi M; Delbari Z; Khodadadi F; Ayatollahi H; Rassouli FB
Iran J Basic Med Sci; 2020 May; 23(5):616-622. PubMed ID: 32742599
[TBL] [Abstract][Full Text] [Related]
17. Conferone, a coumarin from
Rafatpanah H; Golizadeh M; Mahdifar M; Mahdavi S; Iranshahi M; Rassouli FB
Int J Immunopathol Pharmacol; 2023; 37():3946320231197592. PubMed ID: 37688389
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide-induced cytotoxicity in A549 cells: The role of necroptosis.
Jamil M; Mohammadi-Bardbori A; Safa O; Nikpoor AR; Bakhtari A; Mokhtarinejad M; Zadeh SN; Shadboorestan A; Omidi M
Drug Res (Stuttg); 2023 Sep; 73(7):417-425. PubMed ID: 37230480
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.
Rangwala F; Williams KP; Smith GR; Thomas Z; Allensworth JL; Lyerly HK; Diehl AM; Morse MA; Devi GR
BMC Cancer; 2012 Sep; 12():402. PubMed ID: 22963400
[TBL] [Abstract][Full Text] [Related]
20. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
Lam SK; Leung LL; Li YY; Zheng CY; Ho JC
Lung Cancer; 2016 Nov; 101():111-119. PubMed ID: 27794399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]